DCF — EMANATE HEALTH MEDICAL CENTER
Enterprise Value: $-406.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-406.1M
Enterprise Value
$-137.3M
PV of Cash Flows
$-268.8M
PV of Terminal Value
$-432.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $516.7M | $-20.5M | -4.0% | $-42.4M | $-38.5M |
| Year 2 | $532.2M | $-15.8M | -3.0% | $-38.3M | $-31.7M |
| Year 3 | $548.2M | $-10.8M | -2.0% | $-34.0M | $-25.5M |
| Year 4 | $564.6M | $-8.3M | -1.0% | $-32.2M | $-22.0M |
| Year 5 | $581.6M | $-7.1M | -1.0% | $-31.7M | $-19.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-406.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$501.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.044637401292377796
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5